IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 268 filers reported holding IMMUNOGEN INC in Q2 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,109,000 | -21.5% | 700,000 | -6.7% | 1.20% | -19.7% |
Q2 2023 | $14,152,500 | +205.2% | 750,000 | -40.0% | 1.49% | +193.1% |
Q1 2023 | $4,637,500 | -37.7% | 1,250,000 | -16.7% | 0.51% | -34.4% |
Q4 2022 | $7,440,000 | +13.9% | 1,500,000 | +36.4% | 0.78% | +13.5% |
Q3 2022 | $6,534,000 | +21.0% | 1,100,000 | -8.3% | 0.68% | +11.4% |
Q2 2022 | $5,400,000 | -20.4% | 1,200,000 | -15.8% | 0.61% | -8.2% |
Q1 2022 | $6,783,000 | -39.3% | 1,425,000 | -5.0% | 0.67% | -10.0% |
Q4 2021 | $11,175,000 | +61.7% | 1,500,000 | +23.1% | 0.74% | +53.2% |
Q3 2021 | $6,911,000 | -14.0% | 1,218,850 | 0.0% | 0.48% | -11.0% |
Q2 2021 | $8,032,000 | +80.3% | 1,218,850 | +121.6% | 0.54% | +75.2% |
Q1 2021 | $4,455,000 | +133.7% | 550,000 | +205.6% | 0.31% | -44.3% |
Q3 2014 | $1,906,000 | +62.9% | 180,000 | +82.4% | 0.56% | +60.8% |
Q2 2014 | $1,170,000 | +6.4% | 98,702 | +33.9% | 0.35% | +5.2% |
Q1 2014 | $1,100,000 | -25.0% | 73,702 | -26.3% | 0.33% | -42.5% |
Q4 2013 | $1,467,000 | – | 100,000 | – | 0.57% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 10,906,962 | $69,914,000 | 3.04% |
Fernwood Investment Management, LLC | 224,500 | $1,439,000 | 0.77% |
Telemetry Investments, L.L.C. | 272,000 | $1,744,000 | 0.66% |
Schonfeld Strategic Advisors LLC | 865,356 | $5,547,000 | 0.45% |
Virtus ETF Advisers LLC | 53,977 | $346,000 | 0.43% |
Endurant Capital Management LP | 210,800 | $1,351,000 | 0.41% |
SPHERA FUNDS MANAGEMENT LTD. | 500,000 | $3,205,000 | 0.38% |
TWIN FOCUS CAPITAL PARTNERS, LLC | 113,216 | $726,000 | 0.37% |
Orbimed Advisors | 2,834,126 | $18,167,000 | 0.23% |
PINNACLE ASSOCIATES LTD | 1,322,231 | $8,476,000 | 0.16% |